Skip to content
S6337Senate2023-2024 SessionSame asA6779

Let Pharmacists Give Injections

Official title

“Relates to the administration of certain medications by a pharmacist”

Sponsor Neil D. BreslinSD-46Affects Education
Status
Senate Floor Calendar
Impact
7/10
Significant
Outcome
Companion signed

Bill progress

Signed via A6779

What's happening

This bill expands pharmacists' authority to administer injectable medications for mental health and substance use disorders, with updated training, notification, and recordkeeping requirements.

Why it matters

  1. Expands the range of injectable medications pharmacists can administer for mental health and substance use disorders. moving beyond limiting injections to the deltoid muscle and clarifying authority to also administer emergency treatments like anaphylaxis medications, which could increase access to critical care in community settings.

  2. Strengthens notification and follow-up requirements. mandates pharmacists notify the prescribing clinician within five days of administering, not administering, or if the patient experiences side effects, using interoperable electronic systems when possible. This could improve care coordination, safety monitoring, and patient outcomes.

  3. Updates training and competency standards. removes detailed, prescriptive language on training content but maintains the requirement for training “satisfactory to the commissioner,” emphasizing continued competency regarding both medications and patient populations. This gives regulatory bodies flexibility to adjust standards as treatments and best practices evolve.

  4. Accelerates implementation timelines. sets a specific effective date of April 1, 2024, and allows for immediate regulatory action to prepare for these changes, potentially speeding up access for patients needing these services.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Pharmacists and pharmacies

    The bill would remove the deltoid-only restriction on mental health and substance use disorder injections, authorize related emergency anaphylaxis medications and require training satisfactory to state education and health officials.

  • Patients receiving injectable mental health or substance use disorder treatment

    The bill would allow pharmacy administration beyond the deltoid muscle while requiring an initial injection and a prescriber's determination of eligibility for maintenance treatment before pharmacy treatment begins.

  • Licensed prescribers

    Pharmacists would need patient-specific prescriptions or orders, notify prescribers within five days after administration and also report missed administrations, side effects or adverse reactions.

  • State education and health officials

    The bill would require coordination on pharmacist training and administration rules and set April 1, 2024, as the effective date for the underlying pharmacy authorization.

Headline styles

Let Pharmacists Give Injections

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Neil D. Breslin

Senator · Senate District 46

Chair, Ethics And Internal GovernanceChair, Insurance

No co-sponsors yet.

History

  1. Substituted by A6779A
  2. Ordered to third reading cal.1686
  3. Committee discharged and committed to rules
  4. Print number 6337a
  5. Amend (t) and recommit to higher education
  6. Referred to higher education

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A6779Assembly

Let Pharmacists Give Injections

Signed by Governor · Sponsor John T. McDonald III

Impact 7 · SignificantSigned into law

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6337--A

2023-2024 Regular Sessions

IN SENATE

April 14, 2023

Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the education law, in relation to the administration of certain medications by a pharmacist; and to amend chapter 802 of the laws of 2022 amending the education law relating to the definition of the practice of pharmacy, in relation to the effectiveness thereof

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The opening paragraph, subparagraph 1 and subparagraph 3 of paragraph b of subdivision 22 of section 6802 of the education law, as amended by chapter 5 of the laws of 2023, are amended to read as follows:

The injection of medications [into the deltoid muscle] for the treatment of mental health and substance use disorder, as prescribed or ordered by a licensed prescriber, acting within the scope of their practice in this state and in accordance with regulations promulgated by the commissioner, in consultation with the department of health and any other state agencies as necessary, provided that:

(1) Such administration is conducted pursuant to a valid patient-specific prescription or patient-specific order that authorizes a pharmacist to administer medications approved by the U.S. Food and Drug Administration for the treatment of mental health and substance use disorder [and the]. The pharmacist [notifies] shall notify the licensed prescriber that the administration is complete within five days and shall convey such information to the prescriber by making an entry into an interoperable electronic medical records system, an electronic prescribing technology or a pharmacy record, or by using facsimile, electronic transmission or other electronic means. If an electronic means described in this subparagraph is not available to the pharmacist at the time of

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD10677-08-3

communication, the pharmacist or pharmacist's designee may communicate the information by telephone. Notification shall also be required if a patient does not receive an administration or if the patient experiences any side effects or adverse reactions to the medications. Administration in a pharmacy [may] shall not commence until after the patient has received the initial injection and is considered eligible for maintenance treatment by the licensed prescriber.

(3) Such activity is conducted in accordance with regulations, promulgated or adopted by the commissioner, in consultation with the department of health and any other state agencies, as necessary, which shall include requirements for the following:

(i) [Training accredited by the accreditation council for pharmacy education, that may include educational experiences obtained through pharmacy school curricula, or a similar health authority or professional body appropriate for the medications being administered and their respective patient populations. Such training must be satisfactory to the commissioner and the department of health, in consultation with the board of pharmacy and any other state agencies, as necessary, which shall include, but not be limited to learning modules on techniques for administration by injections, indications, precautions, and contraindications in the use of agent or agents; record keeping and information; and handling emergencies, including anaphylaxis, needle-sticks and cardiopulmonary resuscitation.

(ii)] Maintaining continued competency regarding the populations served and medications administered.

[(iii)] (ii) Pre-administration patient consent and education regarding common side effects, drug interactions, injection site reactions and other information routinely provided to patients upon dispensing. If a patient is unable to provide consent, the pharmacist must obtain consent from a person legally responsible when the recipient is incapable of consenting.

[(iv)] (iii) When administering an injection in a pharmacy, the pharmacist shall provide an area for the injection that provides for the patient's privacy.

[(v) Record keeping and reporting of such administration by electronic transmission or facsimile to the patient's licensed prescriber, and, to the extent practicable, make himself or herself available to discuss the outcome of such injection, including any adverse reactions, with the licensed prescriber acting within their scope of practice.

(vi)] (iv) Ensuring that only U.S. Food and Drug Administration approved medications are administered.

§ 2. Subdivisions 3 and 8 of section 6801 of the education law, subdivision 3 as added by chapter 563 of the laws of 2008, and subdivision 8 as added by chapter 802 of the laws of 2022, are amended to read as follows:

3. No pharmacist shall administer immunizing agents or injectable medications for the treatment of mental health and substance use disorder without receiving training satisfactory to the commissioner and the commissioner of health which shall include, but not be limited to, techniques for screening individuals and obtaining informed consent; techniques of administration; indications, precautions and contraindications in the use of agent or agents; record keeping of immunization and information; and handling emergencies, including anaphylaxis and needlesticks.

8. A licensed pharmacist within their lawful scope of practice may administer injectable medications [into the deltoid muscle] and medications required for emergency treatment of anaphylaxis related to such administration, pursuant to section six thousand eight hundred two of this article, for the treatment of mental health and substance use disorder, as prescribed or ordered by a licensed prescriber, acting within their scope of practice in this state and in accordance with regulations, including but not limited to regulations promulgated by the commissioner in consultation with any other state agencies, as necessary.

§ 3. Section 3 of chapter 802 of the laws of 2022 amending the education law relating to the definition of the practice of pharmacy, is amended to read as follows:

§ 3. This act shall take effect [one year after it shall have become a law] April 1, 2024. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed by the commissioner of education on or before such date.

§ 4. This act shall take effect immediately; provided however, that the amendments to sections 6801 and 6802 of the education law made by sections one and two of this act shall take effect on the same date and in the same manner as chapter 802 of the laws of 2022, takes effect. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to the administration of certain medications by a pharmacist; and to amend chapter 802 of the laws of 2022 amending the education law relating to the definition of the practice of pharmacy, in relation to the effectiveness thereof

Summary of specific provisions

Section one amends the opening paragraph and subparagraph 1 of paragraph b of 2 subdivision 22 of section 6802 of the education law to remove the limitation of injections into the deltoid and provides a notification requirement within five days of administration of the injection.

Section two amends subdivision 8 of section 6801 of the education law to remove the limitation of injections into the deltoid in the pharmacist scope of practice.

Read the full memo (685 words)

Section three sets forth the effective date.

Justification

New York is one of 11 states that do not allow pharmacist medication administrative authority for non-vaccine items and one of 14 states that do not allow pharmacists the administrative authority to administer Long-Acting Injectable Antipsychotics.

There is a public health need in the US for increased access to behav- ioral health services-including Long Acting Injectables (LAIS) that are either used for mental health or substance use disorders. The challenge with the oral forms of these medications is non-adherence, which is very prevalent. For example, half of patients diagnosed with schizophrenia do not take their medications as prescribed and re-admission rates are five times higher in patients who are non-adherent than those who are adher- ent. This high rate of non-adherence can be linked to many reasons including the side effects of the medications, diversion and other factors that can contribute to clinical relapses and hospitalizations which can cause significant distress for the patient and high costs to the health care system. More importantly, treatment goals are not being met which is of benefit to the patient and society as a whole.

Due to the high accessibility of community pharmacies that are much closer to patient's homes and have more extensive hours of operations than a clinic setting, pharmacists are well suited to administer LAIs in the community setting. Additionally, pharmacies are able to provide on-demand or appointment-based delivery as has been implemented for vaccine administration and they are well equipped to maintain a large medication inventory, something medical offices are not well-suited for. Moreover, the ability to allow pharmacists to administer LAI's in the community setting will also help reduce the stigma of patients who need to go to a specific type of clinic for their disease which at times is not only a challenge with transportation but also with how they feel they will be perceived. In addition, the COVID-19 pandemic may make a patient less likely to travel to a traditional medical setting. Finally, in the community pharmacy setting, pharmacies are able to include poli- cies and procedures for communicating care delivery back to the patient's health care provider and other coordination services which is critical information that a provider cannot always access easily. This bill will improve patient access and adherence while reducing stigma at a time when a growing number of individuals in our communities are struggling with mental health concerns and/or a substance use disease.

Prior legislative history

New bill.

Fiscal implications

None.

Effective date

This act shall take effect April 1, 2024. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed by the commissioner of education on or before such date. This act shall take effect immediately; provided however, that the amendments to sections 6801 and 6802 of the education law made by sections one and two of this act shall take effect on the same date and in the same manner as chapter 802 of the laws of 2022, takes effect. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effec- tive date are authorized to be made and completed on or before such date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.